Please assess the completion status of the following clinical trial:

Trial Title: Eight Week Primaquine Regimen for the Treatment of Vivax Malaria

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE3
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Patients diagnosed with P. vivax parasitaemia~* Patients over 3 years~* Patients with G6PD deficiency to a safety trial~* Patients without G6PD deficiency to all other groups.~Exclusion Criteria:~* Children under the age of three~* Pregnant / breast feeding women~* Patients with severe clinical anaemia \[Hb\<7g/dl\]~* Patients with P. falciparum~* Patients unavailable for the duration of study.~* Patients who have taken antimalarial drugs in the 2 weeks prior to consultation.~* Patients with concomitant infections or whose general health is considered too poor.

- Gender: ALL
- Minimum Age: 3 Years
- Maximum Age: 70 Years
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).